Clinical Genetics Unit, Department of Women and Children's Health, IRP Città della Speranza, University of Padova, Padova, Italy.
Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
Hum Mutat. 2018 Mar;39(3):406-414. doi: 10.1002/humu.23376. Epub 2017 Dec 18.
Mutations in COQ8B cause steroid-resistant nephrotic syndrome with variable neurological involvement. In yeast, COQ8 encodes a protein required for coenzyme Q (CoQ) biosynthesis, whose precise role is not clear. Humans harbor two paralog genes: COQ8A and COQ8B (previously termed ADCK3 and ADCK4). We have found that COQ8B is a mitochondrial matrix protein peripherally associated with the inner membrane. COQ8B can complement a ΔCOQ8 yeast strain when its mitochondrial targeting sequence (MTS) is replaced by a yeast MTS. This model was employed to validate COQ8B mutations, and to establish genotype-phenotype correlations. All mutations affected respiratory growth, but there was no correlation between mutation type and the severity of the phenotype. In fact, contrary to the case of COQ2, where residual CoQ biosynthesis correlates with clinical severity, patients harboring hypomorphic COQ8B alleles did not display a different phenotype compared with those with null mutations. These data also suggest that the system is redundant, and that other proteins (probably COQ8A) may partially compensate for the absence of COQ8B. Finally, a COQ8B polymorphism, present in 50% of the European population (NM_024876.3:c.521A > G, p.His174Arg), affects stability of the protein and could represent a risk factor for secondary CoQ deficiencies or for other complex traits.
COQ8B 基因突变导致类固醇耐药性肾病综合征伴可变的神经受累。在酵母中,COQ8 编码一种辅酶 Q(CoQ)生物合成所需的蛋白质,其确切作用尚不清楚。人类有两个同源基因:COQ8A 和 COQ8B(以前称为 ADCK3 和 ADCK4)。我们发现 COQ8B 是一种与内膜外周相关的线粒体基质蛋白。当 COQ8B 的线粒体靶向序列(MTS)被酵母 MTS 取代时,它可以补充 ΔCOQ8 酵母菌株。该模型用于验证 COQ8B 突变,并建立基因型-表型相关性。所有突变均影响呼吸生长,但突变类型与表型严重程度之间没有相关性。事实上,与 COQ2 不同,COQ 生物合成的残留与临床严重程度相关,携带 COQ8B 等位基因功能降低的患者与携带 null 突变的患者的表型没有差异。这些数据还表明该系统具有冗余性,其他蛋白(可能是 COQ8A)可能部分补偿 COQ8B 的缺失。最后,COQ8B 多态性(存在于 50%的欧洲人群中:NM_024876.3:c.521A > G,p.His174Arg),影响蛋白稳定性,可能是继发 CoQ 缺乏或其他复杂表型的风险因素。